Beyond PSA: Utility of a Urine Gene Expression Assay for Early Prostate Cancer Detection

Webinar Jan 05, 2022

In this webinar, Dr. John Smith and Dr. Albala explore the breakthrough ExoDx™ Prostate Test, a non-invasive risk assessment tool for prostate cancer. They discuss its accuracy and ability to guide treatment decisions, highlighting its potential to revolutionize prostate cancer management and improve patient outcomes through personalized medicine.